[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,111,438
  • Shares Outstanding, K 385,873
  • Annual Sales, $ 4,662 M
  • Annual Income, $ 836,300 K
  • EBIT $ 1,033 M
  • EBITDA $ 1,285 M
  • 60-Month Beta 1.40
  • Price/Sales 5.96
  • Price/Cash Flow 26.01
  • Price/Book 9.40

Options Overview Details

View History
  • Implied Volatility 41.07% (+1.03%)
  • Historical Volatility 45.57%
  • IV Percentile 39%
  • IV Rank 26.70%
  • IV High 77.57% on 10/30/25
  • IV Low 27.78% on 08/05/25
  • Expected Move (DTE 1) 1.16 (1.60%)
  • Put/Call Vol Ratio 0.27
  • Today's Volume 5,063
  • Volume Avg (30-Day) 4,647
  • Put/Call OI Ratio 1.04
  • Today's Open Interest 95,664
  • Open Int (30-Day) 97,375
  • Expected Range 71.21 to 73.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.60
  • Number of Estimates 10
  • High Estimate $0.64
  • Low Estimate $0.58
  • Prior Year $0.48
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.72 +27.54%
on 04/29/26
73.10 -1.04%
on 05/26/26
+13.02 (+21.95%)
since 04/28/26
3-Month
56.72 +27.54%
on 04/29/26
73.91 -2.12%
on 03/02/26
-1.09 (-1.48%)
since 02/27/26
52-Week
54.11 +33.69%
on 11/07/25
89.98 -19.60%
on 07/30/25
-14.64 (-16.83%)
since 05/28/25

Most Recent Stories

More News
The DexCom Stock Turnaround Is Showing Real Signs of Life

DexCom (DXCM) shares have put together an encouraging short-term bounce as the company maps out a multi-year growth algorithm. The stock currently carries a 8% “Sell” rating, but that’s up from the...

DXCM : 72.34 (+2.96%)
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

Dexcom has announced a new continuous glucose monitoring system designed for people using basal insulin, oral therapies or GLP-1 receptor agonists 1 . The new system will be available...

DXCM : 72.34 (+2.96%)
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and...

DXCM : 72.34 (+2.96%)
Stocks Settle Sharply Lower as Bond Yields Jump on Inflation Fears

The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -1.24%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.54%. June E-mini...

MSTR : 151.64 (-1.66%)
ALK : 46.59 (+1.35%)
MPC : 251.33 (+1.73%)
HL : 17.59 (+3.84%)
CDE : 18.59 (+4.20%)
ADI : 419.01 (+0.51%)
GLXY : 30.13 (+0.53%)
COIN : 182.25 (+4.87%)
OXY : 57.32 (+0.76%)
PZZA : 34.65 (+4.24%)
AMD : 518.09 (+4.55%)
SCCO : 194.88 (+3.80%)
Stocks Slide as Inflation Fears Lift Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.91%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.30%. June E-mini S&P futures...

MSTR : 151.64 (-1.66%)
ALK : 46.59 (+1.35%)
MPC : 251.33 (+1.73%)
HL : 17.59 (+3.84%)
CDE : 18.59 (+4.20%)
GLXY : 30.13 (+0.53%)
COIN : 182.25 (+4.87%)
OXY : 57.32 (+0.76%)
FANG : 194.14 (+0.67%)
PZZA : 34.65 (+4.24%)
AMD : 518.09 (+4.55%)
SCCO : 194.88 (+3.80%)
Stocks Tumble on Inflation Jitters

The S&P 500 Index ($SPX ) (SPY ) today is down -1.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.64%. June E-mini S&P futures...

ALK : 46.59 (+1.35%)
MPC : 251.33 (+1.73%)
HL : 17.59 (+3.84%)
CDE : 18.59 (+4.20%)
OXY : 57.32 (+0.76%)
FANG : 194.14 (+0.67%)
PZZA : 34.65 (+4.24%)
AMD : 518.09 (+4.55%)
SCCO : 194.88 (+3.80%)
SPY : 754.60 (+0.55%)
MU : 923.52 (-0.53%)
AAL : 14.65 (-1.81%)
Are Wall Street Analysts Bullish on DexCom’s Stock?

Although DexCom has significantly underperformed the broader market over the past year, Wall Street analysts continue to maintain a very bullish outlook on the company’s long-term growth prospects.

XLV : 150.88 (+1.40%)
$SPX : 7,563.63 (+0.58%)
DXCM : 72.34 (+2.96%)
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

Will Add Two Independent Directors with MedTech and Operations Experience to be Named at a Later Date Reconstituted Operations and Innovation Committee Will Expand Mandate to Oversee Operations,...

DXCM : 72.34 (+2.96%)
Sell in May and Go Away—Starting With These 3 Stocks

Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call.

MSFT : 426.99 (+3.47%)
META : 635.29 (+0.01%)
GOOGL : 390.13 (+0.33%)
ABT : 86.30 (+0.72%)
CL : 91.66 (+0.41%)
ORCL : 203.70 (+6.67%)
DXCM : 72.34 (+2.96%)
BKH : 73.09 (-1.89%)
AMZN : 274.00 (+0.79%)
2 Mid-Cap Stocks with Impressive Fundamentals and 1 We Question

2 Mid-Cap Stocks with Impressive Fundamentals and 1 We Question

BSY : 32.21 (+0.47%)
SEIC : 88.60 (-1.20%)
DXCM : 72.34 (+2.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 74.70
2nd Resistance Point 73.67
1st Resistance Point 71.97
Last Price 72.34
1st Support Level 69.24
2nd Support Level 68.21
3rd Support Level 66.51

See More

52-Week High 89.98
Fibonacci 61.8% 76.28
Last Price 72.34
Fibonacci 50% 72.04
Fibonacci 38.2% 67.81
52-Week Low 54.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.